The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nutlin-3: A novel potential therapeutic in p53 wild-type ovarian carcinomas.
Erin Rebecca King
No relevant relationships to disclose
Lisa K Mullany
No relevant relationships to disclose
JoAnne S Richards
No relevant relationships to disclose
David Marc Gershenson
No relevant relationships to disclose
Kwong-Kwok Wong
No relevant relationships to disclose